Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Prevalence and risk factors of HIV and syphilis, and knowledge and risk behaviors related to HIV/AIDS among men who have sex with men in Chongqing, China.

Ma W, Wu G, Zheng H, Zhang W, Peng Z, Yu R, Wang N.

J Biomed Res. 2016 Mar;30(2):101-111. doi: 10.7555/JBR.30.20150057.

2.

Host factors and early treatments to restrict paediatric HIV infection and early disease progression.

Gianesin K, Petrara R, Freguja R, Zanchetta M, Giaquinto C, De Rossi A.

J Virus Erad. 2015 Jul 1;1(3):140-7. Review.

3.

Tracing defaulters in HIV prevention of mother-to-child transmission programmes through community health workers: results from a rural setting in Zimbabwe.

Vogt F, Ferreyra C, Bernasconi A, Ncube L, Taziwa F, Marange W, Wachi D, Becher H.

J Int AIDS Soc. 2015 Oct 12;18:20022. doi: 10.7448/IAS.18.1.20022.

4.

Implementation and Operational Research: Decentralization Does Not Assure Optimal Delivery of PMTCT and HIV-Exposed Infant Services in a Low Prevalence Setting.

Edmonds A, Feinstein L, Okitolonda V, Thompson D, Kawende B, Behets F.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):e130-9. doi: 10.1097/QAI.0000000000000781.

5.

Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants.

Zhu Q, Yu Z, Kabashima T, Yin S, Dragusha S, El-Mahdy AF, Ejupi V, Shibata T, Kai M.

Sci Rep. 2015 May 19;5:10323. doi: 10.1038/srep10323.

6.

Alcohol enhances HIV infection of cord blood monocyte-derived macrophages.

Mastrogiannis DS, Wang X, Dai M, Li J, Wang Y, Zhou Y, Sakarcan S, Pena JC, Ho W.

Curr HIV Res. 2014;12(4):301-8.

7.

Patient factors to target for elimination of mother-to-child transmission of HIV.

Mnyani CN, Simango A, Murphy J, Chersich M, McIntyre JA.

Global Health. 2014 May 15;10:36. doi: 10.1186/1744-8603-10-36.

8.

Efficacy of enhanced HIV counseling for risk reduction during pregnancy and in the postpartum period: a randomized controlled trial.

Maman S, Moodley D, McNaughton-Reyes HL, Groves AK, Kagee A, Moodley P.

PLoS One. 2014 May 13;9(5):e97092. doi: 10.1371/journal.pone.0097092.

9.

Pregnant women living with HIV (WLH) supported at clinics by peer WLH: a cluster randomized controlled trial.

Richter L, Rotheram-Borus MJ, Van Heerden A, Stein A, Tomlinson M, Harwood JM, Rochat T, Van Rooyen H, Comulada WS, Tang Z.

AIDS Behav. 2014 Apr;18(4):706-15. doi: 10.1007/s10461-014-0694-2.

10.

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.

Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, Chirwa Z, Ng'ambi W, Bakali A, Phiri S, Myer L, Valeri F, Zwahlen M, Wandeler G, Keiser O; Ministry of Health in Malawi and IeDEA Southern Africa..

AIDS. 2014 Feb 20;28(4):589-98. doi: 10.1097/QAD.0000000000000143.

11.

Expanding contraceptive options for PMTCT clients: a mixed methods implementation study in Cape Town, South Africa.

Hoke T, Harries J, Crede S, Green M, Constant D, Petruney T, Moodley J.

Reprod Health. 2014 Jan 10;11(1):3. doi: 10.1186/1742-4755-11-3.

12.

Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive.

Kellerman SE, Ahmed S, Feeley-Summerl T, Jay J, Kim M, Phelps BR, Sugandhi N, Schouten E, Tolle M, Tsiouris F; Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children..

AIDS. 2013 Nov;27 Suppl 2:S225-33. doi: 10.1097/QAD.0000000000000107. Review.

13.

Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.

Myer L, Daskilewicz K, McIntyre J, Bekker LG.

J Int AIDS Soc. 2013 Sep 16;16:18649. doi: 10.7448/IAS.16.1.18649.

14.

Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study.

Stinson K, Jennings K, Myer L.

PLoS One. 2013 May 16;8(5):e63328. doi: 10.1371/journal.pone.0063328.

15.

Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Vermund SH, Tique JA, Cassell HM, Pask ME, Ciampa PJ, Audet CM.

J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S12-25. doi: 10.1097/QAI.0b013e31829202a2. Review.

16.

Socio-economic, clinical and biological risk factors for mother - to - child transmission of HIV-1 in Muhima health centre (Rwanda): a prospective cohort study.

Bucagu M, Bizimana Jde D, Muganda J, Humblet CP.

Arch Public Health. 2013 Feb 28;71(1):4. doi: 10.1186/0778-7367-71-4.

17.

Immunotherapies to prevent mother-to-child transmission of HIV.

Hicar MD.

Curr HIV Res. 2013 Mar;11(2):137-43. Review.

18.

Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania.

Ziske J, Kunz A, Sewangi J, Lau I, Dugange F, Hauser A, Kirschner W, Harms G, Theuring S.

PLoS One. 2013;8(2):e55633. doi: 10.1371/journal.pone.0055633.

19.

Trends in HIV prevalence among young people in generalised epidemics: implications for monitoring the HIV epidemic.

Mahy M, Garcia-Calleja JM, Marsh KA.

Sex Transm Infect. 2012 Dec;88 Suppl 2:i65-75. doi: 10.1136/sextrans-2012-050789.

20.

Community strategies that improve care and retention along the prevention of mother-to-child transmission of HIV cascade: a review.

Marcos Y, Phelps BR, Bachman G.

J Int AIDS Soc. 2012 Jul 11;15 Suppl 2:17394. doi: 10.7448/IAS.15.4.17394. Review.

Supplemental Content

Support Center